| Actimmune (InterMune Inc) | dosage | IFN-gamma; Immune interferon; Interferon gamma precursor; Interferon gamma-1b |
| Adalimumab | Solution | Ig gamma-1 chain C region; Humira (Abbott Laboratories) |
| Alferon (Interferon Sciences Inc.) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Interferon alfa-n3 |
| Amgen) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Interferon alfacon-1; Infergen (InterMune Inc |
| Anakinra | Solution | ICIL-1RA; IL-1RN; IL-1ra; IL1 inhibitor; IRAP; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| Avonex (Biogen Inc) | dosage | Fibroblast interferon; IFN-beta; Interferon beta precursor; Interferon beta-1a |
| Betaseron (Chiron Corp) | dosage | Fibroblast interferon; IFN-beta; Interferon beta precursor; Interferon beta-1b |
| CD120b | dosage | Etanercept; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Enbrel (Immunex Corp) | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Etanercept |
| Etanercept | Kit;liquid;powder for solution | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2] | dosage | CD120b; Etanercept; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Fibroblast interferon | dosage | Interferon beta-1a; IFN-beta; Interferon beta precursor; Avonex (Biogen Inc) |
| Fibroblast interferon | dosage | Interferon beta-1b; IFN-beta; Interferon beta precursor; Betaseron (Chiron Corp) |
| Filgrastim | Solution | G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Neupogen (Amgen Inc.) |
| Filgrastim | dosage | Pegfilgrastim; G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Neulasta (Amgen Inc.) |
| Flebogamma (Instituto Grifols SA) | dosage | Ig alpha-2 chain C region; Immune globulin; Gamunex (Talecris Biotherapeutics) |
| G-CSF | dosage | Filgrastim; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Neupogen (Amgen Inc.) |
| G-CSF | dosage | Filgrastim; Pegfilgrastim; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Neulasta (Amgen Inc.) |
| Gamunex (Talecris Biotherapeutics) | dosage | Ig alpha-2 chain C region; Flebogamma (Instituto Grifols SA); Immune globulin |
| Granulocyte colony-stimulating factor precursor | dosage | Filgrastim; G-CSF; Pegfilgrastim; Lenograstim; Pluripoietin; Neulasta (Amgen Inc.) |
| Granulocyte colony-stimulating factor precursor | dosage | G-CSF; Filgrastim; Lenograstim; Pluripoietin; Neupogen (Amgen Inc.) |
| Humira (Abbott Laboratories) | dosage | Ig gamma-1 chain C region; Adalimumab |
| ICIL-1RA | dosage | Anakinra; IL-1RN; IL-1ra; IL1 inhibitor; IRAP; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| IFN-beta | dosage | Fibroblast interferon; Interferon beta-1a; Interferon beta precursor; Avonex (Biogen Inc) |
| IFN-beta | dosage | Fibroblast interferon; Interferon beta-1b; Interferon beta precursor; Betaseron (Chiron Corp) |
| IFN-gamma | dosage | Interferon gamma-1b; Immune interferon; Interferon gamma precursor; Actimmune (InterMune Inc) |
| IL-1RN | dosage | ICIL-1RA; Anakinra; IL-1ra; IL1 inhibitor; IRAP; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| IL-1ra | dosage | ICIL-1RA; IL-1RN; Anakinra; IL1 inhibitor; IRAP; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| IL1 inhibitor | dosage | ICIL-1RA; IL-1RN; IL-1ra; Anakinra; IRAP; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| IRAP | dosage | ICIL-1RA; IL-1RN; IL-1ra; IL1 inhibitor; Anakinra; Interleukin-1 receptor antagonist protein precursor; Kineret (Amgen Inc) |
| Ig alpha-2 chain C region | dosage | Immune globulin; Flebogamma (Instituto Grifols SA); Gamunex (Talecris Biotherapeutics) |
| Ig gamma-1 chain C region | dosage | Adalimumab; Humira (Abbott Laboratories) |
| Ig gamma-1 chain C region | dosage | Omalizumab; Xolair (Genentech Inc) |
| Immune globulin | Solution | Ig alpha-2 chain C region; Flebogamma (Instituto Grifols SA); Gamunex (Talecris Biotherapeutics) |
| Immune interferon | dosage | IFN-gamma; Interferon gamma-1b; Interferon gamma precursor; Actimmune (InterMune Inc) |
| Infergen (InterMune Inc | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Amgen); Interferon alfacon-1 |
| Interferon alfa-2b | Solution (Injection); Powder for Injection | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Intron A (Schering Corp) |
| Interferon alfa-n1 | Solution (Intramuscular or Subcutaneous Injection) | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Wellferon (GlaxoSmithKline) |
| Interferon alfa-n3 | Solution (injection) | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Alferon (Interferon Sciences Inc.) |
| Interferon alfacon-1 | Solution | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Amgen); Infergen (InterMune Inc |
| Interferon alpha-2 precursor | dosage | Interferon alfa-2b; Interferon alpha-A; LeIF A; Intron A (Schering Corp) |
| Interferon alpha-2 precursor | dosage | Interferon alfa-n1; Interferon alpha-A; LeIF A; Wellferon (GlaxoSmithKline) |
| Interferon alpha-2 precursor | dosage | Interferon alfa-n3; Interferon alpha-A; LeIF A; Alferon (Interferon Sciences Inc.) |
| Interferon alpha-2 precursor | dosage | Interferon alfacon-1; Interferon alpha-A; LeIF A; Amgen); Infergen (InterMune Inc |
| Interferon alpha-2 precursor | dosage | Peginterferon alfa-2a; Interferon alpha-A; LeIF A; Pegasys (Hoffman-La Roche Inc) |
| Interferon alpha-2 precursor | dosage | Peginterferon alfa-2b; Interferon alpha-A; LeIF A; PEG-Intron (Schering Corp) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Interferon alfa-2b; LeIF A; Intron A (Schering Corp) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Interferon alfa-n1; LeIF A; Wellferon (GlaxoSmithKline) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Interferon alfa-n3; LeIF A; Alferon (Interferon Sciences Inc.) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Interferon alfacon-1; LeIF A; Amgen); Infergen (InterMune Inc |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Peginterferon alfa-2a; LeIF A; Pegasys (Hoffman-La Roche Inc) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Peginterferon alfa-2b; LeIF A; PEG-Intron (Schering Corp) |
| Interferon beta precursor | dosage | Fibroblast interferon; IFN-beta; Interferon beta-1a; Avonex (Biogen Inc) |
| Interferon beta precursor | dosage | Fibroblast interferon; IFN-beta; Interferon beta-1b; Betaseron (Chiron Corp) |
| Interferon beta-1a | Solution (Subcutaneous Injection); Solution (Intra- or Peri-lesional Injection) | Fibroblast interferon; IFN-beta; Interferon beta precursor; Avonex (Biogen Inc) |
| Interferon beta-1b | Solution (Subcutaneous Injection); Powder for solution | Fibroblast interferon; IFN-beta; Interferon beta precursor; Betaseron (Chiron Corp) |
| Interferon gamma precursor | dosage | IFN-gamma; Immune interferon; Interferon gamma-1b; Actimmune (InterMune Inc) |
| Interferon gamma-1b | Solution (subcutaneous Injection) | IFN-gamma; Immune interferon; Interferon gamma precursor; Actimmune (InterMune Inc) |
| Interleukin-1 receptor antagonist protein precursor | dosage | ICIL-1RA; IL-1RN; IL-1ra; IL1 inhibitor; IRAP; Anakinra; Kineret (Amgen Inc) |
| Intron A (Schering Corp) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Interferon alfa-2b |
| Kineret (Amgen Inc) | dosage | ICIL-1RA; IL-1RN; IL-1ra; IL1 inhibitor; IRAP; Interleukin-1 receptor antagonist protein precursor; Anakinra |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Interferon alfa-2b; Intron A (Schering Corp) |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Interferon alfa-n1; Wellferon (GlaxoSmithKline) |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Interferon alfa-n3; Alferon (Interferon Sciences Inc.) |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Interferon alfacon-1; Amgen); Infergen (InterMune Inc |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Peginterferon alfa-2a; Pegasys (Hoffman-La Roche Inc) |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Peginterferon alfa-2b; PEG-Intron (Schering Corp) |
| Lenograstim | dosage | Filgrastim; G-CSF; Granulocyte colony-stimulating factor precursor; Pegfilgrastim; Pluripoietin; Neulasta (Amgen Inc.) |
| Lenograstim | dosage | G-CSF; Granulocyte colony-stimulating factor precursor; Filgrastim; Pluripoietin; Neupogen (Amgen Inc.) |
| Neulasta (Amgen Inc.) | dosage | Filgrastim; G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Pegfilgrastim |
| Neupogen (Amgen Inc.) | dosage | G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Filgrastim |
| Omalizumab | Powder for solution | Ig gamma-1 chain C region; Xolair (Genentech Inc) |
| PEG-Intron (Schering Corp) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Peginterferon alfa-2b |
| Pegasys (Hoffman-La Roche Inc) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Peginterferon alfa-2a |
| Pegfilgrastim | Solution | Filgrastim; G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pluripoietin; Neulasta (Amgen Inc.) |
| Peginterferon alfa-2a | Solution | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Pegasys (Hoffman-La Roche Inc) |
| Peginterferon alfa-2b | Powder for solution | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; PEG-Intron (Schering Corp) |
| Pluripoietin | dosage | Filgrastim; G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Pegfilgrastim; Neulasta (Amgen Inc.) |
| Pluripoietin | dosage | G-CSF; Granulocyte colony-stimulating factor precursor; Lenograstim; Filgrastim; Neupogen (Amgen Inc.) |
| TNF-R2 | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; Etanercept; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Tumor necrosis factor receptor 2 | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Etanercept; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Tumor necrosis factor receptor superfamily member 1B precursor | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Etanercept; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Tumor necrosis factor receptor type II | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Etanercept; p75; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| Wellferon (GlaxoSmithKline) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Interferon alfa-n1 |
| Xolair (Genentech Inc) | dosage | Ig gamma-1 chain C region; Omalizumab |
| p75 | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; Etanercept; p80 TNF-alpha receptor; Enbrel (Immunex Corp) |
| p80 TNF-alpha receptor | dosage | CD120b; Etanercept[Contains: Tumor necrosis factor binding protein 2,TBPII,TBP-2]; TNF-R2; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B precursor; Tumor necrosis factor receptor type II; p75; Etanercept; Enbrel (Immunex Corp) |